Visionix

Company Overview

Snapshot

Founded in December 1993, Visionix operates with 51–200 employees. The company was acquired by Revenio Group in June 2026, marking a significant exit in the Health Tech & Life Sciences sector.

Business overview

Visionix develops non-contact 3D eye-measurement systems for eye care professionals and laboratories. The company's core technology is based on proprietary Wavefront technology, which enables detailed analysis of the lens, eye, and other optical systems to identify and quantify higher-order optical aberrations. Visionix has also miniaturized this technology for integration into various instruments, aiming for broad accessibility and affordability. Operating in the Health Tech & Life Sciences sector, Visionix distributes its products globally through direct sales and a network of partners, serving markets in the United States, Canada, and China.

Strategic signal

In June 2026, Visionix was acquired by Revenio Group. This acquisition signals a strategic consolidation within the ophthalmic device market, with Visionix's specialized Wavefront technology likely enhancing Revenio Group's product portfolio and market reach. For investors, this demonstrates the continued value and demand for advanced diagnostic solutions in eye care.

Company Intelligence Q&A

What is Visionix's primary focus?

Visionix specializes in developing non-contact 3D optical measurement systems for eye professionals and related laboratories, utilizing proprietary Wavefront technology for detailed eye analysis.

When was Visionix acquired?

Visionix was acquired by Revenio Group in June 2026.

What is Visionix's employee count?

Visionix operates with 51–200 employees.

Did Visionix enter into any distribution agreements?

In November 2014, Visionix and the Axis Medical Group announced an exclusive distribution agreement.

What was a key strategic partnership for Visionix in China?

In July 2013, Visionix expanded its product line in China through a strategic partnership with Lumenis.